Abstract

Ten-eleven translocation-2 (TET2) is a member of the methylcytosine dioxygenase family of enzymes and has been implicated in cancer and aging because of its role as a global epigenetic modifier. TET2 has a large N-terminal domain and a catalytic C-terminal region. Previous reports have demonstrated that the TET2 catalytic domain remains active independently of the N-terminal domain. As such, the function of the N terminus of this large protein remains poorly characterized. Here, using yeast two-hybrid screening, co-immunoprecipitation, and several biochemical assays, we found that several isoforms of the 14-3-3 family of proteins bind TET2. 14-3-3 proteins bound TET2 when it was phosphorylated at Ser-99. In particular, we observed that AMP-activated protein kinase-mediated phosphorylation at Ser-99 promotes TET2 stability and increases global DNA 5-hydroxymethylcytosine levels. The interaction of 14-3-3 proteins with TET2 protected the Ser-99 phosphorylation, and disruption of this interaction both reduced TET2 phosphorylation and decreased TET2 stability. Furthermore, we noted that protein phosphatase 2A can interact with TET2 and dephosphorylate Ser-99. Collectively, these results provide detailed insights into the role of the TET2 N-terminal domain in TET2 regulation. Moreover, they reveal the dynamic nature of TET2 protein regulation that could have therapeutic implications for disease states resulting from reduced TET2 levels or activity.

Highlights

  • Ten-eleven translocation-2 (TET2) is a member of the methylcytosine dioxygenase family of enzymes and has been implicated in cancer and aging because of its role as a global epigenetic modifier

  • These results provide detailed insights into the role of the TET2 N-terminal domain in TET2 regulation. They reveal the dynamic nature of TET2 protein regulation that could have therapeutic implications for disease states resulting from reduced TET2 levels or activity

  • We demonstrate a critical role for 14-3-3s in protecting TET2 phosphorylation and thereby promoting its stability

Read more

Summary

The abbreviations used are

5mC, 5-methylcytosine; 5hmC, 5-hydroxymethylcytosine; TET, ten-eleven translocation; AML, acute myeloid leukemia; PP2A, protein phosphatase 2A; IP, immunoprecipitation; IB, immunoblotting; CV, control vector; CHX, cycloheximide; KD, kinase-dead; KO, knockout; MEF, mouse embryonic fibroblast; AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide; rPP2A, recombinant PP2A; OKA, okadaic acid; HRP, horseradish peroxidase; ACC, acetyl-CoA-carboxylase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ANOVA, analysis of variance; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; AMPK, AMP-activated protein kinase. Our studies demonstrate the dynamic regulation of TET2 via phosphorylation and phosphatase events that may provide new therapeutic avenues to promote TET2 stability

Results
Discussion
Materials and methods
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call